Feed JAGSNPHARM.BO
JA
Jagsonpal Pharmaceuticals Limited
JAGSNPHARM.BO · BSE
₹230.30 -1.26% (-₹2.95)
1M +4.67%
Market Cap ₹14.9B
P/E Ratio 34.69x
Div. Yield 1.76%
ROE 17.08%
Bulios Fair Price
₹202.15
12.2% downside
Preț actual
₹230.3
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile JAGSNPHARM.BO sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Piotroski F-Score Weak
3/9Valuation
27 /100
Expensive EV/EBITDA 21.95x
P/S 5.20x
P/B 5.41x
Growth
59 /100
Stable Rev. growth 6.66%
FCF growth 0.24%
Book val. growth 20.23%
Profitability
87 /100
Strong Net margin 15.00%
Op. margin 16.93%
FCF margin 16.25%
Quality
78 /100
Excellent ROE 17.08%
ROA 13.60%
Asset turnover 0.91x
Debt
100 /100
Low Current ratio 5.06x
Int. coverage 56.95x
Net debt/EBITDA -0.03x
Stability
44 /100
Moderate Rev. volatility 20.32%
EPS volatility 93.90%
Profitable years 6
Întreabă StockBot despre JAGSNPHARM.BO
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Manish Gupta
Employees
1,025
Headquarters
Gurugram
Evenimente viitoare
04 SEPT.
Ex-Dividend
Ex-dividend date
04 SEPT.
Dividend Payment
Data plății